Trial Profile
Association between genetic polymorphism and adverse events or effectiveness of S-1-based chemotherapy in patients with gastrointestinal cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Oct 2012
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Antineoplastics
- Indications Biliary cancer; Colorectal cancer; Gastric cancer; Pancreatic cancer
- Focus Adverse reactions; Pharmacogenomic
- 01 Mar 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 18 Dec 2009 New trial record